Skip to main content
Caplight Logo









VivoSphere

VivoSphere

Private
Auburn, AlabamaHealthcare & Life Scienceshttps://vivospheres.com/

Last Round

Grant

May 14, 2026

Total Funding Raised

$575,000

Company Overview

VivoSphere is a biotechnology company that develops advanced 3D tissue-engineered models for drug discovery and toxicity testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Hardware Sales

AI Layer

Non-AI

Keywords

3D tissue engineeringpreclinical drug discoveryin vitro modelsorgan-on-a-chiptoxicity testing3D cell culturehigh-throughput screeningcontract research organizationCROdrug screeningmicrospheroidal tissuealternative to animal testingbiotech equipmentassay-ready kitsprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VivoSphere Comparables

Compare VivoSphere with similar companies based on industry and business-model similarity.

VivoSphere comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Obatala Sciences
84%
Altis Biosystems
83%
BiomimX
82%

VivoSphere Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 14, 2026
GrantMay 1, 2025
GrantSep 16, 2024
GrantMay 22, 2024
GrantAug 17, 2023

VivoSphere Investors

Notable investors and investment history

VivoSphere investors
InvestorRounds
NIH RADxGrant
Alabama LaunchpadGrant
National Science FoundationGrant
InvestALGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 16, 2024

    $100K grant received from InvestAL.

Recent news

Latest coverage and updates

  • attends_eventJun 29, 2026

    Vivospheres attended event 2026 Cycle 1 Life Sciences Division finals on May 14th '26.

VivoSphere Filings

Explore SEC and related filing metadata, where available.

VivoSphere filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about VivoSphere's valuation, stock price, and market status.

Is VivoSphere a public or private company?

VivoSphere is a private company.

What is the current stock price of VivoSphere?

VivoSphere is a private company with no public stock price. No recent secondary market data is available.

How much is VivoSphere worth (valuation)?

Valuation information for VivoSphere is not publicly available.

Can I buy VivoSphere stock?

VivoSphere shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was VivoSphere's last funding round?

VivoSphere's most recent funding round was Grant on May 14, 2026.

Who are the main investors in VivoSphere?

Key investors in VivoSphere include NIH RADx, Alabama Launchpad, National Science Foundation, InvestAL.

Will VivoSphere IPO soon?

No public IPO plans have been announced for VivoSphere.

How can I track VivoSphere secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VivoSphere's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAuburn, Alabama
Employee Range3
Year Founded2022
Last FundingMay 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?